Edition:
United States

Cesca Therapeutics Inc (KOOL.PH)

KOOL.PH on Philadelphia Stock Exchange

2.96USD
1 Dec 2017
Change (% chg)

-- (--)
Prev Close
$2.96
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
346
52-wk High
$4.74
52-wk Low
$2.76

Latest Key Developments (Source: Significant Developments)

Cesca Therapeutics Announces Pricing Of Public Offering
Wednesday, 29 Nov 2017 09:07am EST 

Nov 29 (Reuters) - Cesca Therapeutics Inc ::CESCA THERAPEUTICS INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF UP TO 900,000 SHARES OF COMMON STOCK.CESCA THERAPEUTICS INC - PRICED REGISTERED PUBLIC OFFERING AT $3.00 PER SHARE​.  Full Article

Cesca Therapeutics Announces Proposed Public Offering Of Common Stock
Tuesday, 28 Nov 2017 05:20pm EST 

Nov 28 (Reuters) - Cesca Therapeutics Inc ::CESCA THERAPEUTICS INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.  Full Article

Cesca Therapeutics reports quarterly loss per share $0.24
Tuesday, 14 Nov 2017 04:05pm EST 

Nov 14 (Reuters) - Cesca Therapeutics Inc ::Cesca Therapeutics announces financial results for the three months ended September 30, 2017 and provides corporate update.Quarterly loss per share $0.24.Quarterly revenue $3.1 million versus $3.8 million.  Full Article

Empery Asset Management LP reports 5.43 pct passive stake in Cesca Therapeutics
Monday, 15 Aug 2016 05:19pm EDT 

Cesca Therapeutics Inc : Empery Asset Management, LP reports 5.43 pct passive stake in Cesca Therapeutics as of August 4, 2016 - SEC Filing Source - http://bit.ly/2bl8rAM Further company coverage: [KOOL.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Cesca Therapeutics announces pricing of $2.5 mln registered direct offering
Thursday, 4 Aug 2016 09:08am EDT 

Cesca Therapeutics Inc: Cesca Therapeutics announces pricing of $2.5 million registered direct offering .To purchase 600,000 shares of common stock at a purchase price per share of $4.10.  Full Article

Cesca Therapeutics files for mixed shelf of up to $30 mln
Wednesday, 29 Jun 2016 05:21pm EDT 

Cesca Therapeutics Inc :Files for mixed shelf of up to $30.0 million - SEC filing.  Full Article

Cesca Therapeutics submits investigational device exemption supplement for Surgwerks CLI pivotal trial
Wednesday, 1 Jun 2016 11:15am EDT 

Cesca Therapeutics Inc: Cesca therapeutics submits investigational device exemption supplement for Surgwerks CLI pivotal trial .Expects FDA to submit its response to IDE supplement within 30 days of submission.  Full Article

Cesca Therapeutics Q3 revenue $2.8 million
Thursday, 12 May 2016 04:37pm EDT 

Cesca Therapeutics Inc : Says net loss from operations for quarter ended march 31, 2016 was $2.7 million compared to $4.8 million . Expects to submit an ide supplement to fda at end of month detailing a range of changes to pivotal cli trial design . Cesca therapeutics reports third quarter fiscal 2016 results and provides business update .Q3 revenue $2.8 million versus $4.0 million.  Full Article

BRIEF-Cesca Therapeutics Announces Proposed Public Offering Of Common Stock

* CESCA THERAPEUTICS INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK Source text for Eikon: Further company coverage: